Reuters Market Eye - Investors in Bharti Airtel(BRTI.NS) are keenly waiting rival Idea Cellular Ltd's (IDEA.NS) October-December earnings results due later in the day.
Idea is much smaller than Bharti in revenue terms, but both mobile carriers operate on GSM technology and have similar kinds of subscribers.
As well, both companies' mainstay is second-generation (2G) voice although there has been a greater push in recent months to increase revenue from mobile data.
That may help explain why Idea and Bharti shares have seen a correlation of 0.86 in the past three months.
"Idea's numbers would also answer whether the 2G industry is growing or not, which should have bearing on Bharti too," said an analyst tracking the sector.
(Reporting by Abhishek Vishnoi)
FDA warns former Sun Pharma U.S. drug factory over quality concerns
MUMBAI The U.S. Food and Drug Administration has pulled up a former Sun Pharmaceutical drug factory for "knowingly" releasing 27 lots of the hypertension drug clonidine last year, despite proof that the raw materials used may have been contaminated.
Sensex posts worst weekly fall in nearly four months; Fed awaited
The BSE Sensex posted its worst week since early May on Friday, as investors stayed on the sidelines ahead a speech by U.S. Federal Reserve Chair Janet Yellen in Jackson Hole, Wyoming later in the day.
Fed's Mester: Makes sense for U.S. to start raising rates - CNBC
The U.S. Federal Reserve should hike rates again so as not to fall behind in a strengthening economy, Cleveland Fed President Loretta Mester said on Friday.